Grafapex

Active Ingredient(s): Treosulfan
FDA Approved: * January 21, 2025
Pharm Company: * MEDEXUS
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Grafapex 1000 mg/g Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 59137-335
Labeler:
Medexus Pharma, Inc.
Grafapex 5000 mg/5g Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 59137-365
Labeler:
Medexus Pharma, Inc.